PresentationFor this session, we have the pleasure to host from Denali Therapeutics, the CEO, Ryan Watts. Welcome, Ryan, and maybe we kick off by giving us a few minutes on what Denali does.Good afternoon, everyone, and welcome to Morgan Stanley Global Healthcare Conference. I'm Sean Laaman, Head of U.S. mid-cap biotech equity research at the firm. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you do have any questions, ...